The Leuven Faculty of Theology and Religious Studies, was a branch of the Catholic University of Leuven. The faculty traces its history back to its founding in 1432, however it was abolished in 1797 due to the French Revolution. The current faculty was established in 1834, as a part of the Catholic University of Leuven. Following the Belgian Revolution of 1830, which has established the freedom of teaching, this New Catholic University was founded in 1834 in Mechelen by the private initiative of the Belgian bishops. In 1967 the faculty was divided into Flemish and French speaking departments, and they exist today as two separate faculties. Wikipedia.
Agfa - Gevaert NV and Catholic University of Leuven | Date: 2017-01-11
A radiation curable composition for preparing a polymeric membrane includes a) a membrane polymer selected from the group consisting of a polysulfone (PSU), a polyether sulfone (PES), a polyether etherketone (PEEK), a polyvinylchloride (PVC), a polyacrylonitrile (PAN), a polyvinylidene fluoride (PVDF), a polyimide (PI), a polyamide (PA) and copolymers thereof; b) a hydrophobic monomer or oligomer having at least two free radical polymerizable groups independently selected from the group consisting of an acrylate group, a methacrylate group, an acrylamide group, a methacrylamide group, a styrene group, a vinyl ether group, a vinyl ester group, a maleate group, a fumarate group, an itaconate group, and a maleimide group; and c) an organic solvent for the membrane polymer and the hydrophobic monomer. A polymeric membrane and a method for manufacturing the membrane are also disclosed.
Imec and Catholic University of Leuven | Date: 2017-05-03
A method is provided for forming a porous, electrochemically active lithium manganese oxide layer on a substrate, the method comprising: depositing a porous manganese oxide layer on the substrate; providing a Li containing layer on the porous manganese oxide layer; and afterwards performing an annealing step at a temperature in the range between 200C and 400C, thereby inducing a solid-state reaction between the porous manganese oxide layer and the Li containing layer. The method may further comprise, before depositing the porous manganese oxide layer: depositing a seed layer on the substrate. A method of the present disclosure may be used for forming electrode layers of lithium-ion batteries.
Catholic University of Leuven | Date: 2017-01-04
The present invention relates to diagnosis and/or prognosis of cardiovascular disease and cardiovascular events. A prognostic risk score in relation to the cardiovascular events, more particular after intervention, can be determined by counting the number of deregulated genes (or derived proteins) in their isolated monocytes. Deregulation means low expression of COX1 and/or COX4/1, and/or TFAM, and/or RUNX2.
Catholic University of Leuven | Date: 2017-03-22
The patent describes a one-step liquid biphasic catalytic process for converting a carbohydrate-containing feedstock, preferably lignocellulose, to light naphtha (e.g., hexane, pentane, methyl cyclopentane, cyclohexane, etc.) in presence of an acidic reactive aqueous phase and a redox catalyst in the organic extracting/reaction phase. The process provides a cost-effective route for producing light-naphtha components, in presence or not of deoxygenates. The light naphtha components are useful as feedstock for steam and catalytic cracking to produce value-added platform molecules like ethylene and propylene, as precursor for the synthesis of bioaromatics like benzene and as gasoline fuel feedstock, and as fuel additives, (e.g., the concomitantly formed oxygenates) to improve the biological origin of carbon in the fuel.
Imec and Catholic University of Leuven | Date: 2017-06-21
The present invention relates to a semiconductor fin device (100) comprising at least three fins (102-106) arranged in parallel and protruding out from a substrate (111), the fins are separated from each other by shallow trench isolation structures (101), at least a first (102) and a second (106) of the fins protruding to a level higher than an upper surface (107) of the shallow trench isolation structures, the parallel fins are spaced with a first fin spacing (108), with at least one third fin arranged in between a first and a second fin, wherein in a non-protruding region (110) the third fin extends to a level below or equal to the upper surface of the shallow trench isolation structures.
Imec and Catholic University of Leuven | Date: 2017-03-07
An optical semiconductor device comprises, on a substrate, a fin of diamond-cubic semiconductor material and, at the base of the fin, a slab of that semiconductor material, in a diamond-hexagonal structure, that extends over the full width of the fin, the slab being configured as an optically active material. This semiconductor material can contain silicon. A method for manufacturing the optical semiconductor device comprises annealing the sidewalls of the fin, thereby inducing a stress gradient along the width of the fin.
Novel Compound, Pharmaceutically Acceptable Salt Or Optical Isomer Thereof, Method For Preparing The Same, And Pharmaceutical Composition For Prevention Or Treatment Of Viral Diseases Containing Same As Active Ingredient
Korea Research Institute of Chemical Technology and Catholic University of Leuven | Date: 2017-02-15
The present invention relates to a novel compound, to a pharmaceutically acceptable salt or optical isomer thereof, to a method for preparing same, and to a pharmaceutical composition for the prevention or treatment of viral diseases containing same as an active ingredient. The novel compound according to the present invention not only has low cytotoxicity but also has excellent antiviral activity against picornavirus such as coxsackievirus, enterovirus, echovirus, poliovirus and rhinovirus, and thus can be effectively used as a pharmaceutical composition for the prevention or treatment of viral diseases such as infantile paralysis, acute hemorrhagic conjunctivitis, viral meningitis, hand-foot-and-mouth disease, vesicular disease, hepatitis A, myitis, myocarditis, pancreatitis, diabetes, epidemic myalgia, encephalitis, cold, herpangina, foot-and-mouth disease, asthma, chronic obstructive pulmonary disease, pneumonia, sinus infection, or otitis media.
Catholic University of Leuven and Vanderbilt University | Date: 2017-06-07
Imaging mass spectrometry (IMS) has become a prime tool for studying the distribution of biomolecules in tissue. Although IMS data sets can become very large, computational methods have made it practically feasible to search these experiments for relevant findings. However, these methods lack access to an important source of information that many human interpretations rely upon: anatomical insight In this work, we address this need by (1) integrating a curated anatomical data source with an empirically acquired IMS data source, establishing an algorithm-accessible link between item; and (2) demonstrating the potential of such an IMS-anatomical atlas link by applying it towards automated anatomical interpretation of ion distributions in tissue.
Catholic University of Leuven | Date: 2017-06-07
A heating device (100) for heating the surface of a substrate (140). The heating device comprises a gas source (110) comprising an inert material supply inert under the operating conditions of the heating device, the gas source being adapted for supplying a hot jet of a gas comprising at least elements of said inert material on the substrate (140). The gas source (110) is adapted for heating the hot jet of the gas to a temperature above 1500C.
Catholic University of Leuven and Remynd | Date: 2017-07-12
This invention provides novel compounds and the novel compounds for use as a medicine, more in particular for the prevention or treatment of neurodegenerative disorders, more specifically certain neurological disorders, such as disorders collectively known as tauopathies, and disorders characterised by cytotoxic -synuclein amyloidogenesis. The present invention also relates to the use of said novel compounds for the manufacture of medicaments useful for treating such neurodegenerative disorders. The present invention further relates to pharmaceutical compositions including said novel compounds and to methods for the preparation of said novel compounds.